Safety, PK and Efficacy of PCS12852 on Gastric Emptying Rate in Patients With Moderate to Severe Gastroparesis
Public ClinicalTrials.gov record NCT05270460. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2A, Placebo-controlled, Randomized, Dose Response Study of the Safety, Pharmacokinetics and Efficacy of PCS12852 on Gastric Emptying Rate Assessed by 13C Spirulina GEBT in Patients With Moderate to Severe Gastroparesis
Study identification
- NCT ID
- NCT05270460
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Processa Pharmaceuticals
- Industry
- Enrollment
- 25 participants
Conditions and interventions
Conditions
Interventions
- PCS12852 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 8, 2022
- Primary completion
- Sep 28, 2022
- Completion
- Oct 5, 2022
- Last update posted
- Jul 20, 2023
2022
United States locations
- U.S. sites
- 9
- U.S. states
- 7
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Torrance Clinical Research Institute, Inc. | Lomita | California | 90717 | — |
| TriWest Research Associates | San Diego | California | 92108 | — |
| APF Research, LLC | Miami | Florida | 33135 | — |
| International Research Associates, LLC | Miami | Florida | 33183 | — |
| University of Louisville | Louisville | Kentucky | 40202 | — |
| Delta Research Partners | Bastrop | Louisiana | 71220 | — |
| Long Island Gastrointestinal Research Group | Great Neck | New York | 11023 | — |
| M3 Wake Research | Raleigh | North Carolina | 27612 | — |
| Texas Tech University | El Paso | Texas | 79905 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05270460, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 20, 2023 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05270460 live on ClinicalTrials.gov.